No Cover Image

Journal article 132 views 30 downloads

Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research

Zainab Afshan Sheikh Orcid Logo, Helen Yu

Journal of Responsible Innovation, Volume: 11, Issue: 1

Swansea University Author: Helen Yu

  • 70611.VoR.pdf

    PDF | Version of Record

    © 2024 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

    Download (1.88MB)

Check full text

DOI (Published version): 10.1080/23299460.2024.2316363

Abstract

Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structu...

Full description

Published in: Journal of Responsible Innovation
ISSN: 2329-9460 2329-9037
Published: Informa UK Limited 2024
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa70611
first_indexed 2025-10-08T16:02:14Z
last_indexed 2025-11-15T14:32:38Z
id cronfa70611
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2025-11-14T14:55:08.0131166</datestamp><bib-version>v2</bib-version><id>70611</id><entry>2025-10-08</entry><title>Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research</title><swanseaauthors><author><sid>3fa8e58607d4949e7d0d3fa8fa1c2f7d</sid><firstname>Helen</firstname><surname>Yu</surname><name>Helen Yu</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-10-08</date><deptcode>CBAE</deptcode><abstract>Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.</abstract><type>Journal Article</type><journal>Journal of Responsible Innovation</journal><volume>11</volume><journalNumber>1</journalNumber><paginationStart/><paginationEnd/><publisher>Informa UK Limited</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2329-9460</issnPrint><issnElectronic>2329-9037</issnElectronic><keywords>Responsible Research and Innovation; stakeholder engagement; drug discovery; science-society relations; semi-structured interviews</keywords><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-12-31</publishedDate><doi>10.1080/23299460.2024.2316363</doi><url/><notes/><college>COLLEGE NANME</college><department>Management School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>CBAE</DepartmentCode><institution>Swansea University</institution><apcterm>Other</apcterm><funders>This work was supported by the Research Council of Norway under [grant number 294594].</funders><projectreference/><lastEdited>2025-11-14T14:55:08.0131166</lastEdited><Created>2025-10-08T11:31:16.3447591</Created><path><level id="1">Faculty of Humanities and Social Sciences</level><level id="2">School of Management - Business Management</level></path><authors><author><firstname>Zainab Afshan</firstname><surname>Sheikh</surname><orcid>0000-0003-2723-8855</orcid><order>1</order></author><author><firstname>Helen</firstname><surname>Yu</surname><order>2</order></author></authors><documents><document><filename>70611__35636__b0aabc1b9da645b7b4a21da369d193f9.pdf</filename><originalFilename>70611.VoR.pdf</originalFilename><uploaded>2025-11-14T14:52:40.8567296</uploaded><type>Output</type><contentLength>1973186</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>&#xA9; 2024 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2025-11-14T14:55:08.0131166 v2 70611 2025-10-08 Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research 3fa8e58607d4949e7d0d3fa8fa1c2f7d Helen Yu Helen Yu true false 2025-10-08 CBAE Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation. Journal Article Journal of Responsible Innovation 11 1 Informa UK Limited 2329-9460 2329-9037 Responsible Research and Innovation; stakeholder engagement; drug discovery; science-society relations; semi-structured interviews 31 12 2024 2024-12-31 10.1080/23299460.2024.2316363 COLLEGE NANME Management School COLLEGE CODE CBAE Swansea University Other This work was supported by the Research Council of Norway under [grant number 294594]. 2025-11-14T14:55:08.0131166 2025-10-08T11:31:16.3447591 Faculty of Humanities and Social Sciences School of Management - Business Management Zainab Afshan Sheikh 0000-0003-2723-8855 1 Helen Yu 2 70611__35636__b0aabc1b9da645b7b4a21da369d193f9.pdf 70611.VoR.pdf 2025-11-14T14:52:40.8567296 Output 1973186 application/pdf Version of Record true © 2024 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License. true eng http://creativecommons.org/licenses/by/4.0/
title Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
spellingShingle Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
Helen Yu
title_short Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_full Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_fullStr Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_full_unstemmed Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
title_sort Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
author_id_str_mv 3fa8e58607d4949e7d0d3fa8fa1c2f7d
author_id_fullname_str_mv 3fa8e58607d4949e7d0d3fa8fa1c2f7d_***_Helen Yu
author Helen Yu
author2 Zainab Afshan Sheikh
Helen Yu
format Journal article
container_title Journal of Responsible Innovation
container_volume 11
container_issue 1
publishDate 2024
institution Swansea University
issn 2329-9460
2329-9037
doi_str_mv 10.1080/23299460.2024.2316363
publisher Informa UK Limited
college_str Faculty of Humanities and Social Sciences
hierarchytype
hierarchy_top_id facultyofhumanitiesandsocialsciences
hierarchy_top_title Faculty of Humanities and Social Sciences
hierarchy_parent_id facultyofhumanitiesandsocialsciences
hierarchy_parent_title Faculty of Humanities and Social Sciences
department_str School of Management - Business Management{{{_:::_}}}Faculty of Humanities and Social Sciences{{{_:::_}}}School of Management - Business Management
document_store_str 1
active_str 0
description Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.
published_date 2024-12-31T05:30:00Z
_version_ 1851369771137761280
score 11.089572

Similar Items